Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05477277 · ClinicalTrials.gov registry record · NA
Adverse Outcomes and Mortality in Liver Transplant
A NA study of Cirrhosis and Sarcopenia, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05477277: Recruiting NA study of Cirrhosis and Sarcopenia, sponsored by Mayo Clinic.
NCT05477277 is a NA study of Cirrhosis and Sarcopenia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 90,407-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05477277, a NA study of Cirrhosis and Sarcopenia, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
Primary Outcome
The MAsS is a composite score of muscle fat index (% of muscle fat normalized to sex, weight in kg and height in meters) and muscle volume index (muscle volume in liters normalized to patient sex, height in meters and weight in kg)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MAsS
Study Locations (1)
Arizona
- Mayo Clinic Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-11-02 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What NCT05477277 shows while recruiting
NCT05477277 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 90,407-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which MAsS is the first listed.
NCT05477277 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05477277 about?
NCT05477277 is a clinical study titled "Adverse Outcomes and Mortality in Liver Transplant". Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
What is the current status of trial NCT05477277?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-11-02. Estimated completion is 2027-07-01.
What conditions does trial NCT05477277 study?
This clinical trial studies the following conditions: Cirrhosis, Sarcopenia, End Stage Liver DIsease, Sarcopenic Obesity.
What interventions are being tested in trial NCT05477277?
The interventions under investigation include: MAsS (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05477277?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05477277 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05477277's enrollment target sits among peer trials
100 18th of 53 higher than 35 of 53 other Cirrhosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cirrhosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
CirrhosisRx CDS System
RECRUITING · NA
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI